scispace - formally typeset
M

Marco Valgimigli

Researcher at University of Bern

Publications -  772
Citations -  91095

Marco Valgimigli is an academic researcher from University of Bern. The author has contributed to research in topics: Percutaneous coronary intervention & Myocardial infarction. The author has an hindex of 105, co-authored 696 publications receiving 69184 citations. Previous affiliations of Marco Valgimigli include University of Düsseldorf & Erasmus University Medical Center.

Papers
More filters
Journal Article

Radial versus femoral approach in STEMI: what do we know so far?

TL;DR: Current evidence suggests that radial access should become the default access for patients with ACS undergoing invasive management, and corroborating the evidence of radial access as a highly recommendable alternative to femoral access in the setting of primary percutaneous coronary intervention (p-PCI).
Journal ArticleDOI

Operators' experience with radial access for cardiac catheterization in patients with acute coronary syndromes.

TL;DR: A matched operator-patient analysis taking into account for each operator the prior TRA and TFA expertise is being analyzed in the context of MATRIX program, fearing that it slows radial adoption, a life-saving procedure which is supported by large scale randomized trials.
Journal ArticleDOI

Left atrial adaptation in ischemic heart disease: insights from a cardiovascular magnetic resonance study

TL;DR: The extent (but not the type) of LV damage determines LA adaptions which normalizes over time, and LA increases its active contractile function in the acute phase of STEMI to support LV filling.
Journal ArticleDOI

Reply: Use of Clinical Risk Score in an Elderly Population: Need for Ad Hoc Validation and Calibration

TL;DR: It is suggested that PRECISE-DAPT (Predicting Bleeding Complications in Patients Undergoing Stent Implantation and Subsequent Dual Antiplatelet Therapy) should be validated and recalibrated in patients undergoing stent implantation and subsequent dual antiplatelet therapy.